Literature DB >> 2820562

Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities.

H J Hoekstra1, H Schraffordt Koops, W M Molenaar, J Oldhoff.   

Abstract

High-grade soft tissue sarcomas of the extremities continue to pose problems of local disease control and deaths from distant metastases. Between 1969 and 1976, eight patients with primary and six with recurrent high-grade soft tissue sarcomas of the extremities were treated by isolated regional perfusion with cytostatics and local excision. None received systemic adjuvant chemotherapy or external-beam radiotherapy. During the follow-up (median, 13 years) five patients (36%) developed distant metastases. One was cured after resection of a pulmonary metastasis. In one other patient (7%) recurrent local disease was diagnosed after 48 months; he was cured after resection of the local lesion followed by postoperative external beam radiotherapy. The actuarial 5-year and 10-year survival was 69%. Treatment caused no cardiovascular complications and there was no postoperative mortality.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820562     DOI: 10.1002/1097-0142(19871015)60:8<1703::aid-cncr2820600802>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

Review 1.  [Current state of neoadjuvant therapy of soft tissue sarcoma].

Authors:  M Lehnhardt; T Schmitt; M Bischof; A Daigeler; G Egerer
Journal:  Chirurg       Date:  2011-11       Impact factor: 0.955

2.  [Improved intraoperative leak control in cytostatic drug isolation perfusion of tumors of the extremities].

Authors:  M Manner; H Sinn; H Bubeck; C Kettelhack; P Schlag
Journal:  Langenbecks Arch Chir       Date:  1990

3.  Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

Authors:  A M Eggermont; H Schraffordt Koops; J M Klausner; B B Kroon; P M Schlag; D Liénard; A N van Geel; H J Hoekstra; I Meller; O E Nieweg; C Kettelhack; G Ben-Ari; J C Pector; F J Lejeune
Journal:  Ann Surg       Date:  1996-12       Impact factor: 12.969

Review 4.  Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.

Authors:  A M Eggermont; T L ten Hagen
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075

Review 5.  Isolated limb perfusion for extremity sarcoma.

Authors:  B W Feig
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

6.  Rapid measurement of blood leakage during regional chemotherapy.

Authors:  C Alexander; G Omlor; R Berberich; G Gross; G Feifel
Journal:  Eur J Nucl Med       Date:  1993-03

7.  Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.

Authors:  H J Guchelaar; H J Hoekstra; E G de Vries; D R Uges; J W Oosterhuis; H Schraffordt Koops
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

8.  Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion.

Authors:  B van Etten; M R de Vries; M G A van IJken; T E Lans; G Guetens; G Ambagtsheer; S T van Tiel; G de Boeck; E A de Bruijn; A M M Eggermont; T L M ten Hagen
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

9.  Isolated limb perfusion and external beam radiotherapy for soft tissue sarcomas of the extremity: long-term effects on normal tissue according to the LENT-SOMA scoring system.

Authors:  Miriam L Hoven-Gondrie; Katja M J Thijssens; Jan H B Geertzen; Elisabeth Pras; Robert J van Ginkel; Harald J Hoekstra
Journal:  Ann Surg Oncol       Date:  2008-03-11       Impact factor: 5.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.